Purchase Order 75N92E22P00202
Award Date
5/19/22
Potential Completion Date
5/18/23
Potential Value
$13K
Federal Agency
National Human Genome Research Institute
Awardee
Dnanexus, Inc.
Ultimate Awardee
Not listed
NAICS Category
541519 - Other Computer Related Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mountain View, CA 94040, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit company providing cloud-based genomics data management and analysis services. The contract, titled "A Cloud Platform for Evaluating NGS-Based Diagnostic Test Pipelines," has a ceiling value of $1,993,255.79 and runs through April 27, 2018. The contract is a definitive contract with a firm fixed price pricing type. Dnanexus has previously held other federal contracts with the FDA...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Dnanexus, Inc. for the procurement of the DnaNexus bioinformatic cloud computing platform license and support. The total potential value of the contract is $120,000.00, and the period of performance will end on September 18, 2024. The contract does not have a set-aside designation. Dnanexus, Inc. will provide cloud-based genomics...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
This firm-fixed-price delivery order for $631,840.53 was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company specializing in cloud-based genomics data management and analysis services. The award is for Phase III of the FY24 Common Data Harmonization System, a project to develop and maintain cloud-based platforms that support collaboration between researchers and regulatory reviewers, as well as genomic data analysis environments. Dnanexus has...
Dnanexus, Inc. was awarded a firm fixed price delivery order valued at one hundred ninety-four thousand five hundred ninety-eight dollars and thirteen cents ($194,598.13) by the Department of Health and Human Services' Food and Drug Administration (FDA). This delivery order, with a period of performance through September 2023 and no set-aside designation, is issued against Dnanexus' twenty million dollar ($20M) indefinite delivery contract for ongoing provision of the FDA's PrecisionFDA...
This federal contract award was granted by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit corporate entity based in Mountain View, California. The $6,755,725.98 Firm Fixed Price Delivery Order contract is for Dnanexus to provide the PrecisionFDA platform, a FISMA-authorized secure cloud-based data repository and analysis platform for FDA researchers, reviewers, bioinformaticians, and data scientists to enable collaboration on regulatory science and precision medicine...
This is a $1,051,402.26 firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company specializing in cloud-based genomics data management and analysis services. The contract is for the development of a PRISM high-impact platform pilot to support pre-submission validation of electronic common technical documents (eCTDs) and sponsor-reviewer interaction. This contract is not set aside for small businesses, and Dnanexus has been...
Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...
This federal contract award, ID 75N95D25P00053, was issued by the National Institute on Aging, a civilian agency, to Dnanexus, Inc., a for-profit company headquartered in Mountain View, California. The $14,000 firm-fixed-price purchase order is for computing infrastructure providers, data processing, web hosting, and related services to access and utilize the Research Analysis Platform (RAP) for the analysis and storage of large-scale deidentified datasets. This contract is not set aside for...
The Department of Health and Human Services Food and Drug Administration awarded a $2.8 million firm fixed price delivery order contract to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will deliver its cloud-based precisionFDA platform to support the FDA's regulatory science programs over a one year period of performance ending in September 2022. No subcontractors or set aside designations were identified. This contract leverages Dnanexus' existing...